Cisplatin/capecitabine with intensity-modulated radiation therapy in anal squamous cell carcinoma: a preliminary study.
CONCLUSION: In our study, cisplatin/capecitabine combined with IMRT was safe in ASCC patients, with favorable efficacy as an alternative, and is expected to be explored in study with larger sample.
PMID: 33556252 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
More News: Cancer & Oncology | Carcinoma | Gastroenterology | Intensity-Modulated Radiation Therapy | PET Scan | Radiation Therapy | Skin Cancer | Squamous Cell Carcinoma | Study | Thrombocytopenia | Toxicology | Xeloda